Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial (Q28278518)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

object named as

J D Sobel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

B J Kullberg

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M Ruhnke

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

P G Pappas

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

C Viscoli

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

J D Cleary

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

E Rubinstein

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

L W P Church

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

J M Brown

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

H T Schlamm

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

I T Oborska

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

F Hilton

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

M R Hodges

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

366

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1435-1442

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

9495

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for treatment of candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality and costs of acute renal failure associated with amphotericin B therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole salvage treatment of invasive candidiasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Itraconazole IV solution in the treatment of candidemia in non-neutropenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967490-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)67490-9

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16243088%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28278518&oldid=1817745107"